Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular research network [CVRN])

American Journal of Cardiology

Volumn 111, Issue 9, 2013, Pages 1324-1329

  Goldberg, Robert J ^a   Gurwitz, Jerry H ^a,b   Saczynski, Jane S ^a,b   Hsu, Grace ^c   McManus, David D ^a   Magid, David J ^d   Smith, David H ^e   Go, Alan S ^c,f,g  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c DIVISION OF RESEARCH   (United States)

^d Kaiser Permanente Colorado   (United States)

^e CENTER FOR HEALTH RESEARCH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALDOSTERONE RECEPTOR AGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HORMONE RECEPTOR STIMULATING AGENT; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE PLANNING; HEART EJECTION FRACTION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; CARDIOTONIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; MALE; POPULATION SURVEILLANCE; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 84876699100     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.01.276     Document Type: Article

References (25)

1. G.P. Aurigemma, and W.H. Gaasch Clinical practice: diastolic heart failure N Engl J Med 351 2004 1097 1105
2. D. Burkoff, M.S. Maurer, and M. Packer Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 107 2003 656 658
3. F. Bursi, S.A. Weston, M.M. Redfield, S.J. Jacobsen, S. Pakhomov, V.T. Nkomo, R.A. Meverden, and V.L. Roger Systolic and diastolic heart failure in the community JAMA 296 2006 2209 2216
4. K. Hogg, K. Swedberg, and J. McMurray Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis J Am Coll Cardiol 43 2004 317 327
5. F.D. Hobbs, A.K. Roalfe, R.C. Davis, M.K. Davies, and R. Hare Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES) Eur Heart J 28 2007 1128 1134
6. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
7. R.S. Bhatia, J.V. Tu, D.S. Lee, P.C. Austin, J. Fang, A. Haouzi, Y. Gong, and P.P. Liu Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
8. R.T. Campbell, P.S. Jhund, D. Castagno, N.M. Hawkins, M.C. Petrie, and J.V. McMurray What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-Preserved, and I-PRESERVE? J Am Coll Cardiol 60 2012 2349 2356
9. A.S. Go, D.J. Magid, B. Wells, S.H. Sung, A.E. Cassidy-Bushrow, R.T. Greenlee, R.D. Langer, T.A. Lieu, K.L. Margolis, F.A. Masoudi, C.J. McNeal, G.H. Murata, K.M. Newton, R. Novotny, K. Reynolds, D.W. Roblin, D.H. Smith, S. Vupputuri, R.E. White, J. Olson, J.S. Rumsfeld, and J.H. Gurwitz The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research Circ Cardiovasc Qual Outcomes 1 2008 138 147
10. D.J. Magid, J.H. Gurwitz, J.S. Rumsfeld, and A.S. Go Creating a research data network for cardiovascular disease: the CVRN Expert Rev Cardiovasc Ther 6 2008 1043 1045
11. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham Study N Engl J Med 285 1971 1441 1446
12. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr., D.W. Mahoney, K.R. Bailey, and R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
13. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
14. A.S. Go, W.Y. Lee, J. Yang, J.C. Lo, and J.H. Gurwitz Statin therapy and risks for death and hospitalization in chronic heart failure JAMA 296 2006 2105 2111
15. G.C. Fonarow, W.G. Stough, W.T. Abraham, N.M. Albert, M. Gheorghiade, B.H. Greenberg, C.M. O'Connor, J.L. Sun, C.W. Yancy, and J.B. Young Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
16. C.W. Yancy, M. Lopatin, L.W. Stevenson, T. DeMarco, and G.C. Fonarow Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database J Am Coll Cardiol 47 2006 76 84
17. B.A. Steinberg, X. Zhao, P.A. Heidenreich, E.D. Peterson, D.L. Bhatt, C.P. Cannon, A.F. Hernandez, and G.C. Fonarow Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes Circulation 126 2012 65 75
18. Heart Failure Society of America HFSA 2006 comprehensive heart failure practice guideline J Cardiol Fail 12 2006 e1 e122
19. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, T.G. Ganiats, M. Jessup, M.A. Konstam, D.M. Mancini, K. Michl, J.A. Oates, P.S. Rahko, M.A. Silver, L.W. Stevenson, and C.W. Yancy 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
20. M. Senni, and M.M. Redfield Heart failure with preserved systolic function: a different natural history? J Am Coll Cardiol 38 2001 1277 1282
21. The effect of digoxin on mortality and morbidity in patients with heart failure: the Digitalis Investigation Group N Engl J Med 336 1997 525 533
22. B.M. Massie, P.E. Carson, J.J. McMurray, M. Komajda, R. McKelvie, M.R. Zile, S. Anderson, M. Donovan, E. Iverson, C. Staiger, A. Ptaszynska I-PRESERVE Investigators Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
23. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, E.L. Michelson, B. Olofsson, and J. Ostergren Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
24. A.S. Desai, E.F. Lewis, R. Li, S.D. Solomon, S.F. Assmann, R. Boineau, N. Clausell, R. Diaz, J.L. Fleg, I. Gordeev, S. McKinlay, E. O'Meara, T. Shaburishvili, B. Pitt, and M.A. Pfeffer Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction Am Heart J 162 2011 966 972
25. L.H. Lund, L. Benson, U. Dahlström, and M. Edner Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction JAMA 308 2012 2108 2117